FG
PFE icon

Fairman Group’s Pfizer PFE Stock Holding History

Fairman Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.2K Sell
3,288
-4,828
-59% -$126K 0.06% 84
2026
Q1 		$228K Buy
8,116
+4,855
+149% +$129K 0.19% 55
2025
Q4 		$81.2K Buy
3,261
+13
+0.4% +$328 0.06% 82
2025
Q3 		$82.8K Buy
3,248
+14
+0.4% +$346 0.07% 81
2025
Q2 		$78.4K Buy
3,234
+13
+0.4% +$303 0.06% 83
2025
Q1 		$85.1K Buy
3,221
+12
+0.4% +$314 0.08% 79
2024
Q4 		$85.1K Buy
3,209
+12
+0.4% +$325 0.07% 85
2024
Q3 		$92.5K Buy
3,197
+11
+0.3% +$321 0.08% 83
2024
Q2 		$89.1K Buy
3,186
+11
+0.3% +$303 0.09% 86
2024
Q1 		$88.1K Buy
3,175
+272
+9% +$7.55K 0.08% 77
2023
Q4 		$83.6K Buy
+2,903
New +$87.8K 0.08% 82

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fairman Group's PFE Position: Q2 2026 in Review

Fairman Group reduced its Pfizer (PFE) stake by 59% in Q2 2026, selling an estimated $126K and leaving 3,288 shares worth $79.2K. The position accounts for 0.06% of the portfolio, ranked #84.

Fairman Group first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $228K in Q1 2026. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fairman Group held 3,288 shares of Pfizer worth $79.2K as of Q2 2026.
  • Fairman Group sold 4,828 Pfizer shares in Q2 2026, an estimated $126K.
  • Pfizer made up 0.06% of Fairman Group's portfolio in Q2 2026, its #84 holding.
  • Fairman Group first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Fairman Group's Pfizer position peaked at $228K in Q1 2026.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.